Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice againts encephalitis caused by Cryptococcus neoformans

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 3, 2000, Pages 443-450

  Furukawa, K ^a   Sasaki, H ^a   Pollard, R B ^a   Suzuki, F ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; IMIDAZOLE DERIVATIVE; INTERLEUKIN 10; INTERLEUKIN 4; LANOCONAZOLE; MONOCLONAL ANTIBODY; OKT 3; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 4;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; BRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFICACY; ENCEPHALITIS; FUNGUS GROWTH; FUNGUS IDENTIFICATION; GROWTH INHIBITION; IMMUNOSTIMULATION; INFECTION PREVENTION; LUNG; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; SPLEEN LYMPHOCYTE; TH2 CELL; TISSUE DISTRIBUTION;

ANIMALS; ANTIFUNGAL AGENTS; BRAIN; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; ENCEPHALITIS; FLUCONAZOLE; HETEROCYCLIC COMPOUNDS; IMIDAZOLES; LUNG; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; OPPORTUNISTIC INFECTIONS; SPLEEN; TH2 CELLS;

EID: 0033829978     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Fungal infections in patients with AIDS and AIDS-related complex
2. Cryptococcal meningitis in patients with AIDS
3. Pulmonary cryptococcosis
4. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis
5. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis
6. Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS
7. The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 2: Mechanism of the antiviral action
8. Cryptococcosis
9. Mechanisms of cell-mediated immunity in fungal infection
10. The role of T-cell subsets and cytokines in the regulation of infection
11. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection
12. The role of TH1 and TH2 subsets in human infectious diseases
13. Cytokine patterns during the progression to AIDS
14. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
15. Differential regulation of murine T lymphocyte subsets
16. Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles
17. + T cell clones can provide B cell help
18. Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1
19. Human immunodeficiency virus infection, Part II
20. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy
21. + lymphocytes with cytolytic activity
22. Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants
23. Pathogenic roles of type 2 T cell responses on Cryptococcus neoformans infection in MAIDS mice
24. In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent
25. Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent
26. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS
27. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS)
28. Effect of thermal injury on the severity of LP-BM5 MuLV infection in mice
29. Nonencapsulated variant of Cryptococcus neoformans. I. Virulence studies of characterization of soluble polysaccharide
30. Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis
31. Therapy of experimental meningeal and disseminated cryptococcosis
32. Mechanism for the suppression of gamma-interferon responsiveness in mice after thermal injury
33. + contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV
34. Freshly isolated, murine neonatal T cells produce IL-4 in response to anti-CD3 stimulation
35. Cryptococcus neoformans
36. Cryptococcosis in the acquired immuno-deficiency syndrome
37. Fungal infections in patients with AIDS and AIDS-related complex
38. Cryptococcal meningitis in patients with AIDS
39. Azole antifungal agents: Emphasis on new triazoles
40. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon-gamma-independent mechanism
41. In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anti-cytokine antibodies
42. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis
43. Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice